NCT04116697

Brief Summary

The overall goal of this study is to explore the effectiveness of using acupuncture versus aromatherapy, in conjunction with standard of care anti-emetics, to decrease chemotherapy induced nausea, vomiting, and anxiety in breast cancer patients undergoing Adriamycin and Cytoxan. This study also aims to determine if aromatherapy and anti-emetics is more effective than acupuncture and anti-emetics in treating nausea, vomiting, and anxiety in patients receiving Adriamycin and Cytoxan and if acupuncture and anti-emetics is more effective than aromatherapy and anti-emetics in treating nausea, vomiting, and anxiety in patients receiving Adriamycin and Cytoxan.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 3, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 7, 2019

Completed
16 days until next milestone

Study Start

First participant enrolled

October 23, 2019

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2024

Completed
Last Updated

April 13, 2025

Status Verified

July 1, 2022

Enrollment Period

4.9 years

First QC Date

October 3, 2019

Last Update Submit

April 11, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Improvement in Nausea

    Patients will complete an Edmonton Symptom Assessment Scale. Patients will rate their level of nausea from 0-10 with 10 being the worst possible nausea. Patients will also complete a symptom diary where they will track their level of nausea and how often they are nauseous. Patients will also complete an Anti-Emetic Diary which will track how often they are taking their anti-emetic medications to combat nausea.

    45 days

  • improvement in anxiety

    Patients will complete an Edmonton Symptom Assessment Scale. Patients will rate their level of anxiety from 0-10 with 10 being the worst possible anxiety. Patients will also complete a symptom diary where they will track their level of anxiety and how often they are anxious.

    45 days

  • improvement in vomiting

    Patients will complete a symptom diary where they will track how often they vomit. Patients will also complete an Anti-Emetic Diary which will track how often they are taking their anti-emetic medications to combat vomiting.

    45 days

Study Arms (3)

Acupuncture with Anti-Emetics

EXPERIMENTAL
Other: Acupuncture

Aromatherapy with Anti-Emetics

EXPERIMENTAL
Other: Aromatherapy

Control Group

NO INTERVENTION

Interventions

Acupuncture is a form of alternative medicine in which thin needles are inserted into the body.

Acupuncture with Anti-Emetics

Aromatherapy is a form of alternative medicine in which you will inhale aromatic plant extracts and essential oils.

Aromatherapy with Anti-Emetics

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
i) Inclusion * At least 18 years of age on the day of signing informed consent * Patient has a diagnosis of breast cancer * Patient is planned to start Adriamycin and Cytoxan chemotherapy ii) Exclusion * Patients who are unable to adhere to the protocol or treatment schedule * Patients who have a concurrent illness or take medication that induces nausea independent of chemotherapy * Patients undergoing radiotherapy or hormone therapy during chemotherapy treatments * Patients who have a sensitive and/or poor sense of smell * Patients who are allergic to essential oils, specifically peppermint, ginger, and/or lavender * Patients who are already using essential oils or acupuncture for symptom management and are unwilling to stop while participating in this study * Patients who are afraid of or unwilling to receive acupuncture stimulation * Patients who are allergic to stainless steel needles * Thrombocytopenia (Platelets \< 20,000) * Patients who have received aromatherapy and/or acupuncture treatment within 1 week of starting treatment on this study

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Englewood Health

Englewood, New Jersey, 07631, United States

Location

MeSH Terms

Conditions

NauseaVomitingAnxiety Disorders

Interventions

Acupuncture TherapyAromatherapy

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsMind-Body TherapiesPhytotherapySensory Art TherapiesPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 3, 2019

First Posted

October 7, 2019

Study Start

October 23, 2019

Primary Completion

October 1, 2024

Study Completion

October 1, 2024

Last Updated

April 13, 2025

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations